Diagnosis of Skin Cancer: From the Researcher Bench to the Patient's Bedside

In the study of Várvölgyi et al., it was revealed that plasma osteopontin levels displayed a significant association with the probability of metastatic melanoma, which was similar to serum S100B levels. [...]this publication underlines that combining different biomarkers shows great clinical potential [7]. In addition to advancing diagnostic techniques, diverse novel treatment options have also emerged for more optimal management of skin cancer [26,27]. Lázár et al.’s study emphasizes the crucial role of surgical treatment in large, locally advanced melanomas to achieve long-term disease control in addition to systemic therapy [30]. Zhang, W.; Zeng, W.; Jiang, A.; He, Z.; Shen, X.; Dong, X.; Feng, J.; Lu, H. Global, regional and national incidence, mortality and disability-adjusted life-years of skin cancers and trend analysis from 1990 to 2019: